Study Title

Multi-cohort Investigational Study to Evaluate the Impact of Pelvic Mp-3TMRI and Whole-body 68Ga-PSMA PET/CT for Diagnosis of Clinically-significant Prostate Cancer and Pre-surgical Staging.

Study Details

Description:

BIOPSTAGE is a prospective, non-randomized, diagnostic, multi-cohort investigational study to evaluate the impact of pelvic Multi-parametric 3-Tesla magnetic resonance imaging (mp-3TMRI) and whole-body 68Ga-PSMA PET/CT for diagnosis of clinically-significant prostate cancer and pre-surgical staging.

Sponsor:

Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori

Contacts:

Oriana Nanni

oriana.nanni@irst.emr.it

+390543739266

Federica Matteucci, MD (Study Chair)

federica.matteucci@irst.emr.it

+390543739100

Government Study Link:

NCT03465579 - Click here to see study on

ClinicalTrials.gov

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468